Skip to content
  • ABOUT
        • MISSION/HISTORY
        • DIRECTORS/STAFF
        • SUPPORT
        • INTERNSHIPS
        • FINANCIAL INFORMATION
        • JOBS
        • CONTACT US
  • WASTEWATCHER
  • MEDIA
        • CONGRESSIONAL RATINGS
        • PORKER OF THE MONTH
        • PRESS RELEASES
        • COMMENTARY
  • ISSUES
    • CONGRESSIONAL PIG BOOK
      • Earmark Database
      • PRIME CUTS
      • ISSUE BRIEFS
      • AGENCY COMMENTS
    • DEFENSE
      • AVIATION & SPACE
      • F-35 JOINT STRIKE FIGHTER
      • PROCUREMENT
    • INNOVATION & TECHNOLOGY POLICY CENTER
      • ANTITRUST
      • ARTIFICIAL INTELLIGENCE
      • BIOPHARMACEUTICALS
      • INTELLECTUAL PROPERTY
      • PRIVACY
      • TECHNOLOGY AND INNOVATION
      • TELECOMMUNICATIONS
    • GENERAL WASTE
      • AGRICULTURE REFORM
      • POSTAL SERVICE
      • TAXES
      • TRANSPORTATION
    • HEALTH AND SCIENCE
      • PRICE CONTROLS
      • GOVERNMENT RUN HEALTHCARE
      • 340B DRUG DISCOUNT PROGRAM
      • PHARMACY BENEFIT MANAGERS
      • TOBACCO HARM REDUCTION
    • STATE ISSUES
  • ITPC
        • ANTITRUST
        • ARTIFICIAL INTELLIGENCE
        • BIOPHARMACEUTICALS
        • INTELLECTUAL PROPERTY
        • PRIVACY
        • TECHNOLOGY AND INNOVATION
        • TELECOMMUNICATIONS
  • CCAGW
DONATE
Facebook X-twitter Icon-instagram-1 Icon-youtube

Medicare

Big Government, Biopharmaceuticals, CMS, General Waste, Healthcare, Medicaid, Medicare, Medicare/aid

The Human Cost of Pharmaceutical Price Controls is Too High

July 23, 2022 Christina Smith

Price controls will result in the loss of life due to a lack of future research and development. 

The Senate Should Not Implement Price Controls on Pharmaceuticals
Big Government, Biopharmaceuticals, CMS, General Waste, Government Waste, Healthcare, Medicare, Medicare/aid, Pharmaceuticals

The Senate Should Not Implement Price Controls on Pharmaceuticals

July 1, 2022 Christina Smith

Price controls on pharmaceuticals will not lower prices and will lead to fewer future cures. 

Big Government, Biopharmaceuticals, Biosimilars, General Waste, Government Waste, Healthcare, Medicare, Medicare/aid, Pharmaceuticals

Price Controls in the BBBA Will Destroy the Development of Future Cures

January 29, 2022 Christina Smith

The price controls found in the BBBA leave patients worse off.

Price Controls Will Create an Invisible Graveyard of Americans
Big Government, Biopharmaceuticals, CMS, General Waste, Healthcare, Medicaid, Medicare, Medicare/aid, Pharmaceuticals

Price Controls Will Create an Invisible Graveyard of Americans

December 18, 2021 Christina Smith

The Build Back Better Act will cost lives by devastating the development of future cures.

Obamacare Survives Third Court Challenge
Healthcare, CMS, General Waste, Medicare, Medicare/aid, Obamacare

Obamacare Survives Third Court Challenge

June 18, 2021 Elizabeth Wright

The Supreme Court tossed out ObamaCare lawsuit, California et al v. Texas, stating the plaintiffs have no standing.

Healthcare, Budget, CMS, General Waste, Medicare, Medicare/aid

Lack of Trust in Public Health Authorities Will Impact Debate on Medicare for All

May 28, 2021 Elizabeth Wright

The U.S. public health system has a trust problem due to their handling of COVID-19.

Healthcare, Big Government, Biopharmaceuticals, General Waste, Intellectual Property, Medicaid, Medicare, Medicare/aid, Property Rights

Sen. Elizabeth Warren Offers More Dangerous Healthcare Ideas

January 11, 2020 Elizabeth Wright

Essentially it is Speaker Nancy Pelosi’s (D-Calif.) socialistic drug discount plan, H.R. 3, on steroids.

Healthcare, Biopharmaceuticals, Medicaid, Medicare, Medicare/aid, Pharmaceuticals

CBO Releases the “Savings” Expected from Speaker Pelosi’s Drug Pricing Bill

December 7, 2019 Elizabeth Wright

H.R. 3 exerts so much government authority over the pharmaceutical industry.

Healthcare, CMS, General Waste, Medicare, Medicare/aid, Obamacare

CMMI is Neither Centered nor Innovative

November 17, 2016 Elizabeth Wright

The Center for Medicare and Medicaid Innovation (CMMI) sounds like it should be involved in ground-breaking, state-of-the-art healthcare projects and programs.  However, the center was created in the Patient Protection and Affordable Care Act (ACA), better known as Obamacare, which in and of itself raises red flags. CMMI is run by the Centers for Medicare […]

Healthcare, CMS, Medicare, Medicare/aid, Pharmaceuticals

Morning Joe Is Wrong: Medicare Does Negotiate Drug Prices

October 12, 2016 Elizabeth Wright

Today on the Morning Joe Show, a false narrative was perpetuated: Medicare does not negotiate drug prices. The show’s eponymous host, Joe Scarborough, called for free-marketers to call Congress and demand that the government negotiate Medicare drug prices. Joe needs to supervise his producers’ research better.  The free market is very much involved in negotiating […]

Posts pagination

Previous 1 2 3 Next

Search

Citizens Against Government Waste works to eliminate waste, fraud, abuse, and mismanagement in government through research and public education.

  • MISSION/HISTORY
  • DIRRECTORS/STAFF
  • SUPPORT
  • FINANCIAL INFORMATION
  • CONTACT US
  • CCAGW
  • 1-800-USA-DEBT ®
  • MEDIA@CAGW.ORG
  • 317 MASSACHUSETTS AVENUE, N.E.
    SUITE 300
    WASHINGTON, D.C. 20002

© Citizens Against Government Waste